Kristopher Hanson sold $388k of MPLT
General Counsel at MapLight Therapeutics, Inc.. 13,917 shares at an average of $27.89, traded May 4, 2026, filed May 6, 2026.
Score components
- +15RoleOfficer
- +16Trade size$388k at market
- 0Share of holdings soldSold 7.3% of holdings
- +15Cluster6 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001789970-26-000008, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 4, 2026 | SOpen-market sale Voting Common Stock10b5-1 | -9,030 | $27.50 | $248k | 181,135 | May 6, 2026 |
| May 4, 2026 | SOpen-market sale Voting Common Stock10b5-1 | -3,908 | $28.29 | $111k | 177,227 | May 6, 2026 |
| May 4, 2026 | SOpen-market sale Voting Common Stock10b5-1 | -296 | $29.56 | $8,750 | 176,931 | May 6, 2026 |
| May 4, 2026 | SOpen-market sale Voting Common Stock10b5-1 | -683 | $30.08 | $21k | 176,248 | May 6, 2026 |
Related signals
Other insiders at MapLight Therapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 12Weak | MapLight Therapeutics, Inc. | Kristopher Hanson General Counsel | $193k 16,509 shares | -11% | |
| 45Moderate | MapLight Therapeutics, Inc. | Christopher A. Kroeger Chief Executive Officer | $3.2M 118,235 shares | -8% | |
| 21Weak | MapLight Therapeutics, Inc. | Erin Pennock Foff Chief Medical Officer | $127k 4,438 shares | -1% | |
| 26Weak | MapLight Therapeutics, Inc. | Kristopher Hanson General Counsel | $419k 13,917 shares | -8% | |
| 45Moderate | MapLight Therapeutics, Inc. | Christopher A. Kroeger Chief Executive Officer | $1.9M 68,491 shares | -4% | |
| 10Weak | MapLight Therapeutics, Inc. | James Woodruff Lillie Chief Scientific Officer | $20k 721 shares | -0% | |
| 40Moderate | MapLight Therapeutics, Inc. | Erin Pennock Foff Chief Medical Officer | $1.4M 50,280 shares | -13% | |
| 45Moderate | MapLight Therapeutics, Inc. | Christopher A. Kroeger Chief Executive Officer | $1.4M 49,744 shares | -3% | |
| 40Moderate | MapLight Therapeutics, Inc. | James Woodruff Lillie Chief Scientific Officer | $1.5M 51,707 shares | -18% | |
| 45Moderate | MapLight Therapeutics, Inc. | Jonathan Gillis CAAO and PAO | $2.1M 69,835 shares | -28% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.